Telerehabilitation in COPD

Sponsor
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05053061
Collaborator
(none)
21
1
1
5.2
4

Study Details

Study Description

Brief Summary

The prevalence of chronic obstructive pulmonary disease (COPD) in Turkey is 10%. Patients with COPD have a decreased physical capacity. Decreased physical activity in COPD patients causes an increase in all-cause mortality. Pulmonary rehabilitation contributes to increasing physical capacity and quality of life in COPD patients. However, a limited number of patients have access to pulmonary rehabilitation. Some of the patients drop out of pulmonary rehabilitation due to reasons such as transport difficulties, low social support, and low professional support. In addition, disruption of daily routine is one of the important reasons for this situation. Telerehabilitation can enable more patients to access pulmonary rehabilitation. Education and exercise programs can be followed with telerehabilitation in patients with COPD. An increase in exercise capacity and a decrease in dyspnea have been achieved with telerehabilitation in COPD patients.

Different technologies such as telephone, video conferencing or web sites can be used for telerehabilitation. Also, mobile phone was used to telerehabilitation. To make pulmonary telerehabilitation completely patient-based, we have developed an application suitable for smartphones. The application contains videos which showing how to perform pulmonary rehabilitation exercise videos, and it allows the participants to follow up compliance with pulmonary rehabilitation daily. The application will be downloaded to the smartphones of the participants, and it will be shown how to use the application. Participants will not be shown pulmonary rehabilitation exercises.

This study aims to evaluate the effectiveness of telerehabilitation with the application program on physical capacity, quality of life, and dyspnea perception in COPD patients.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Application program for pulmonary rehabilitation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
21 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Does Pulmonary Rehabilitation With Telerehabilitation Increase Physical Capacity in Patients With Chronic Obstructive Pulmonary Disease
Actual Study Start Date :
Aug 25, 2021
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Jan 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Telerehabilitation Arm

Behavioral: Application program for pulmonary rehabilitation
Exercise videos for pulmonary rehabilitation

Outcome Measures

Primary Outcome Measures

  1. 6-min walk test (6MWT) [8 weeks]

    exercise capacity

Secondary Outcome Measures

  1. Short Form-36 (SF-36) [8 weeks]

    Quality of life

  2. St George's Respiratory Questionnaire [8 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 years

  • Being diagnosed with COPD

  • Not have previously participated in pulmonary rehabilitation

  • To able to use smartphone

Exclusion Criteria:
  • Under age 18

  • Pregnancy

  • Have previously participated in pulmonary rehabilitation

  • Having any malignacy

  • Having any disorder that limit exercise

Contacts and Locations

Locations

Site City State Country Postal Code
1 1University of Health Sciences Turkey, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Intensive Care Unit İzmir Turkey 35110

Sponsors and Collaborators

  • Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cenk Kirakli, M.D., Professor Doctor, Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT05053061
Other Study ID Numbers:
  • IGHCEAH-ICU6
First Posted:
Sep 22, 2021
Last Update Posted:
Sep 22, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Cenk Kirakli, M.D., Professor Doctor, Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital

Study Results

No Results Posted as of Sep 22, 2021